MedTrace Logo

Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy

NCT00433368 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2007-02-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether L-Ornithine L-Aspartate is effective for the improvement of Overt Hepatic Encephalopathy.

Conditions

  • Hepatic Encephalopathy

Interventions

DRUG

L-Ornithine L-Aspartate

Sponsors & Collaborators

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Wasim Jafri, MD; FRCP · Chairman Department of Medicine, Aga Khan University Hospital

  • Shahab Abid, MD · Associate Professor, Department of Medicine, Aga Khan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Completion
2004-09-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00433368 on ClinicalTrials.gov